Certain biologics for psoriasis may reduce cardiometabolic burden
In the treatment of patients with psoriasis, use of certain biologic drugs appears to reduce aortic vascular inflammation and cardiometabolic risk biomarkers, including C-reactive protein and interleukin-6, according to a study.
